Frank Bartel
Institute of Pathology
Faculty of Medicine
University of Halle-Wittenberg
Halle/Saale
Germany
Name/email consistency: high
- Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival. Bartel, F., Jung, J., Böhnke, A., Gradhand, E., Zeng, K., Thomssen, C., Hauptmann, S. Clin. Cancer Res. (2008)
- Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis. Bartel, F., Schulz, J., Böhnke, A., Blümke, K., Kappler, M., Bache, M., Schmidt, H., Würl, P., Taubert, H., Hauptmann, S. Int. J. Cancer (2005)
- Expression of alternatively and aberrantly spliced transcripts of the MDM2 mRNA is not tumor-specific. Bartel, F., Pinkert, D., Fiedler, W., Kappler, M., Würl, P., Schmidt, H., Taubert, H. Int. J. Oncol. (2004)
- Amplification of the MDM2 gene, but not expression of splice variants of MDM2 MRNA, is associated with prognosis in soft tissue sarcoma. Bartel, F., Meye, A., Würl, P., Kappler, M., Bache, M., Lautenschläger, C., Grünbaum, U., Schmidt, H., Taubert, H. Int. J. Cancer (2001)